chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Unwell; Chills; Fever; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Unwell), CHILLS (Chills), PYREXIA (Fever) and ASTHENIA (Weakness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to mRNA-1273. On an unknown date, the patient experienced MALAISE (Unwell), CHILLS (Chills), PYREXIA (Fever) and ASTHENIA (Weakness). At the time of the report, MALAISE (Unwell), CHILLS (Chills), PYREXIA (Fever) and ASTHENIA (Weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Non significant follow up received on 27-APR-2021, no new information
It was reported that a 28 year old female received a TD Adult vaccination on 3/14/00. Reportedly, on 3/15/00, the pt developed erythema, swelling and a bruise at the injection site. The pt reportedly recovered from this experience.
3 y.o. patient was given adult dose of Hep B vaccination. No adverse reactions were reported by parents or child's primary doctor. RN at Medical Group consulted with our clinic Doctor and spoke to parent's regarding possible side affects or reactions that could occur from receiving this adult does of the Hep B vaccine.
I developed a sore throat, runny nose, I was coughing, I used a home COVID-19 test that came back positive. I called my doctor's office to have a telehealth visit to discuss my positive COVID-19 and symptoms. I did not receive any prescription medication; I was given advice on over-the-counter medication. I choose to not to take any medications, it only took ten days for me to get over the everything.
At the time I got covid in January 2022 I started getting headaches regularly,  but not continuous.  They are piercing usually at my temples. I still get them. I use acetaminophen 500mg x2 occasionally if the headaches last. I have not contacted my Doctor.
Information has been received from a doctor of pharmacy concerning a 60 year old female patient with diabetes and no drug reactions or allergies, who on 01-DEC-2011 was vaccinated intramuscularly in her left arm, with a 0.5 ml dose of PNEUMOVAX 23 (Lot number 671176/0985AA, Exp. Date: March 2013). There was no concomitant medication. The doctor of pharmacy reported that "after receiving PNEUMOVAX 23", on approximately 01-DEC-2011, the patient experienced severe arm pain. The pain was from the injection site down to her elbow. There was no redness or swelling. No lab diagnostics studies were performed. No treatment was given for the experience. At the time of the report, the patient had not recovered. The patient sought medical attention by making a phone call to doctor of pharmacy. Severe arm pain and the injection site pain down to the elbow were considered to be disabling by the doctor of pharmacy since the patient could not lift her arm. Additional information has been requested.
Started out as red line at injection site (left arm), then became red, hot, swollen, very itchy, burned.
CDC revised administration of Covid vaccine by eliminating the monovalent and advising to administer with first dose bivalent. Days later it was advised to increase the initial dose of 6 months- 5 years bivalent Moderna to the 6 years and up. This vaccine was administered prior to the increase being communicated to us. It was only recognized when we attended a Moderna information session. This was not communicated until April 28th through the local Health Dept.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch Generalized-Mild, Additional Details: patient waited in the store for the 15min duration and did not feel any symptoms. started feeling symptoms at home and decided to go to the ER. she was given a steroid shot in the ER and a prescription for benadryl
Information has been received from a licensed visiting nurse concerning a 16 female who in February 2008, was vaccinated IM with a 0.5mL dose of GARDASIL. Concomitant suspect vaccination included VARIVAX. Other concomitant vaccinations included tetanus toxoid and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. In less than two minutes post vaccination the patient stopped breathing. The patient was treated with ammonia salts but it took one minute for the patient to take a breath rather then immediately. The patient then urinated while in the waiting room. The patient went to the emergency room for observation. No laboratory diagnostics were performed. The patient recovered on the same day that the vaccination was administered. No product quality complaint was involved. This is one of two reports from the same source. The breathing difficulty and urinary incontinence were considered to be other important medical events. Additional information has been requested.
Tennis ball size swelling  of the  shot site, painful and hot to touch.  Pain and tenderness in armpit. Went to urgent care as symptoms worsen.
Information has been received from a health professional concerning a 9 year old female with egg allergy and no pertinent medical history who on 05-OCT-2000 was vaccinated with the first dose of VARIVAX (Merck). On 14-AUG-2009 the patient was vaccinated subcutaneously with the second dose 0.5 mL of VARIVAX (Merck) (Lot # 664702/0727Y). There was no concomitant medication. On 14-AUG-2009 the patient's mother called the office that the patient's left deltoid was red, swollen and hot to touch where the injection was administered. No treatment required and no lab diagnostic studies were performed. At the time of the report, the events persisted. The patients sought unspecified medical attention. Caller would not be sending the form to Merck. No further information is available.
Rupture in gastrointestinal tract; Fecal impaction; This case was reported by a nurse via call center representative and described the occurrence of fecal impaction in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 day after receiving Shingrix, the patient experienced fecal impaction (serious criteria GSK medically significant) and injury to gastrointestinal tract. On an unknown date, the outcome of the fecal impaction was recovered/resolved and the outcome of the injury to gastrointestinal tract was unknown.   It was unknown if the reporter considered the fecal impaction and injury to gastrointestinal tract to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The patient received Shingrix vaccine in left deltoid. She stated the next day she experienced fecal impaction and she had to manually remove the fecus because she thought it might rupture her gastrointestinal tract. This incident lasted for about 4 hour and was resolved.  Additional information was unspecified. The reporter gave consented to follow up.
One hour after immunization, pt became nauseated, lightheaded with chest pain. Went to ER to receive IV fluids.
swollen lymph nodes; fever; chills; nausea; diarrhea; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), DIARRHOEA (diarrhea) and LYMPHADENOPATHY (swollen lymph nodes) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), DIARRHOEA (diarrhea) and LYMPHADENOPATHY (swollen lymph nodes). On 27-Mar-2021, PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), DIARRHOEA (diarrhea) and LYMPHADENOPATHY (swollen lymph nodes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.
Erythema at the injection site. Swelling and pain at the injection site. A large nodule forming at the injection site. Red rash at the injection site.
got the 2nd vaccine on Thursday and already had symptoms from 1st vaccine but became weaker, vomiting, diarrhea. headache went to the ER Sunday . She was coherent just weak. Did Xray of stomach found out she had colitis , started her on antibiotics and admitted her and by the next morning She started having delusions, almost like having a seizure. on blood work her magnesium was low. She started retaining fluid.  Thought maybe she had stroke but CT showed nothing. Now she doesn't know who she is and just repeating numbers. Pt is currently in the ICU. She has a feeding tube now do to not eating.
Covid arm 2 days after vaccine.  Raised warm sore itchy area at injection site about 3" diameter.   Started this morning.   Had same thing after 7 days with first shot.  Was told to report here if it happened again.  Will take Tylenol and Benedryl.
My milk supply (breastfeeding)  completely stopped about 1-2 weeks after the shot. I noticed my supply lowering about 3-5 days after my second shot.   I also have a lot of constant pressure on my right arm where I received my first shot.
This spontaneous report as received from a pharmacy intern refers to an unspecified patient of unknown age. The patient's medical history was not reported. On 23-JUN-2014 the patient was vaccinated with ZOSTAVAX. (dose, frequency were not reported) (lot # J003360, expiry date: 21-JUN-2014. Concomitant medications were not reported. On 23-JUN-2014, the patient administered expired dose of ZOSTAVAX which was expired on 21-JUN-2014. No adverse effects reported. The pharmacy intern was asked for potency information. Potency supported. The outcome of expired dose of ZOSTAVAX administered was unknown.
8:00 Moderna Vaccine given (first dose) 8:14 Patient head was wobbly, face puffy, lips cyanotic, BP dropped to 110/74, pt c/o palpitations, dizziness and weakness of lower extremeties, O2 administered 8:20 Administered 1 ml of Adrenalin IM on left arm- patient felt better with only c/o weakness of the legs, profusion on lips noted 8:45 Paramedics came, no other medications given and brought patient to hospital for further evaluation
Patient received vaccine and 5 minutes later started hyperventilating and saying she experienced chest pressure. Daughter stated that patient had history of anxiety attacks. Nurse coached patient with breathing exercises and patient stated she felt better. Medics on the scene took vitals at 1037, blood pressure was 174/79. Patient signed Medical form.
I did not have an adverse reaction to the vaccine. On 11/23/2022, I started not feeling well with a sore throat, headache, sneezing and coughing. I test positive for COVID-19 on 12/25/2022 with a home test. On Monday, I contacted my doctor, and I was not eligible for the PAXLOVID due to other health issued. I was given a prescription for ZPAK which helped with my symptoms. As of today, I continue to have congestion.
pt recv vax 14FEB97 & on 4MAR97 pt devel a red raised rash consisting of approx seven blotches the size of a dime located on face, chest, & head;
This spontaneous report as received from a other health professional refers to a patient of unknown age. 01-AUG-2017, the patient was vaccinated with an expired dose of GARDASIL 9 (lot # L045711, 08-MAY-2017) for prophylaxis. No adverse effect reported.
was administered two doses as a first dose; This case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number E344C, expiry date 1st April 2023) for an unknown indication.   Co-suspect products included Herpes zoster (Shingrix) (batch number E344C, expiry date 1st April 2023) for an unknown indication.   On 29th October 2021, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On 29th October 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.   It was unknown if the reporter considered the overdose to be related to Shingrix and Shingrix.  Additional details were reported as follows: The patient had received two doses of Shingrix as a first dose, which led to overdose. The reporter wanted any information if a patient received an extra dose of Shingrix. The patient had granted consent for follow-up.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved. It was unknown if the reporter considered the pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a pharmacist for herself. The age at the vaccination was not reported. The patient experienced soreness for a couple of hours after receiving SHINGRIX. The patient did not provide vaccine information.
Fever, chills, body aches, pain, swelling at injection site, lethargic, dizziness, nausea
Injection site rash; This is a spontaneous report from a non-contactable Other HCP. A 46-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EL8982) via an unspecified route of administration in right arm on 21Jan2021 12:00AM (at the age of 46-year-old) at single dose for COVID-19 immunisation. Relevant medical history included environmental allergies as well as topical product allergies in soaps and cosmetics but no medications. Concomitant medications were not reported. The patient experienced injection site rash on first dose on an unspecified date. The event was not resolved.  No follow-up attempts are possible. No further information is expected.
I was admitted to the ER on 4/12/21 with dizziness, lightheadedness, vertigo, some auditory issues, shortness of breath, swelling/puffiness of legs and feet, unusual coldness in extremities, and some minor pain in chest. CT-Scan revealed DVT in left leg and PEs in both lungs. Was given two shots of heparin over a 24-hour period and then Xarelto 15mg (oral) the following day.
Lightheadedness and nausea, soreness at injection site, weakness in arms bilaterally. Onset of complaints one hour post-injection. Pt reported reaction to medical staff approximately five hours post onset.
Red spots all over body for over 72 hours, 72 hours of a fever, 72 hours of an upset stomach
COVID arm; itchiness arm pretty significantly; swelling arm pretty significantly; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (itchiness arm pretty significantly) and VACCINATION SITE SWELLING (swelling arm pretty significantly) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (itchiness arm pretty significantly) and VACCINATION SITE SWELLING (swelling arm pretty significantly). At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (itchiness arm pretty significantly) and VACCINATION SITE SWELLING (swelling arm pretty significantly) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.  This case concerns a patient of an unknown age and gender with no relevant medical history, who experienced the unexpected event of Vaccination Site Reaction and expected events of Vaccination Site Pruritus and Vaccination Site Swelling. The events occurred on an unknown date after receiving the second dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the second dose was disclosed. The events Vaccination Site Pruritus and Vaccination Site Swelling are consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This case concerns a patient of an unknown age and gender with no relevant medical history, who experienced the unexpected event of Vaccination Site Reaction and expected events of Vaccination Site Pruritus and Vaccination Site Swelling. The events occurred on an unknown date after receiving the second dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the second dose was disclosed. The events Vaccination Site Pruritus and Vaccination Site Swelling are consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
30 to 40 minutes after shot - neck pain,  sharp pains through whole left side body,  lower left back pain with 2 mysterious bruises that came on lower left back not bumped  evening of shot - whole left arm and hand ache and pain, hurt to move hand, body aches, ache at injection site  1st or 2nd evening after shot - left arm and hand didn't want to work or move smoothly "like dying battery" flickery or off on operation, but normal movement by morning   by one week most symptoms gone -BUT- still ache left arm and hand and still ache left neck  Today and yesterday sharp pain under left rib came back
Fever, nausea, hives like rash on face, chest, ears, neck, back. Weakness, heart racing.
tooth pain; upper right side jaw pain (bone); tooth sensitivity to hot and cold; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (tooth pain), PAIN IN JAW (upper right side jaw pain (bone)) and HYPERAESTHESIA TEETH (tooth sensitivity to hot and cold) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concomitant products included PREDNISONE, HYDROCORTISONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (ANTIBIOTIC EAR) and HYDROCODONE for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced TOOTHACHE (tooth pain), PAIN IN JAW (upper right side jaw pain (bone)) and HYPERAESTHESIA TEETH (tooth sensitivity to hot and cold). At the time of the report, TOOTHACHE (tooth pain), PAIN IN JAW (upper right side jaw pain (bone)) and HYPERAESTHESIA TEETH (tooth sensitivity to hot and cold) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment also includes dentist visit, dental X-rays, physician follow-up.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 19-AUG-2015, the patient was vaccinated with an improperly stored dose of VAQTA (lot # L009445, exp.date: 01-JUN-2017) (strength, dose and route were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Stomach pain; Coughing; Left arm pain at injection site; Headache; Low grade temperature 100.9 degrees Fahrenheit; Malaise; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) at the age of 68 years as dose 1, single and administration date 17Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma", start date: 2010 (unspecified if ongoing), notes: Asthma, Autoimmune, all her life for Asthma, 2010. The patient's concomitant medications were not reported. Vaccination history included: Pneumonia vaccine. (Eight weeks prior had pneumonia vaccine.), for Immunization. The following information was reported: HEADACHE (non-serious) with onset 24Feb2021 20:00, outcome "recovered" (26Feb2021), described as "Headache"; PYREXIA (non-serious) with onset 24Feb2021 20:00, outcome "recovered" (26Feb2021), described as "Low grade temperature 100.9 degrees Fahrenheit"; MALAISE (non-serious) with onset 24Feb2021 20:00, outcome "recovered" (26Feb2021), described as "Malaise"; COUGH (non-serious) with onset 25Feb2021 10:00, outcome "recovered" (26Feb2021), described as "Coughing"; ABDOMINAL PAIN UPPER (non-serious) with onset 25Feb2021 13:00, outcome "recovered" (26Feb2021), described as "Stomach pain"; VACCINATION SITE PAIN (non-serious) with onset 24Feb2021 20:00, outcome "recovered" (25Feb2021), described as "Left arm pain at injection site". Relevant laboratory tests and procedures are available in the appropriate section.  Aadditional Information: Patient confirmed information above. It has been a while since patient received it. First dose was back in 24Feb2021. She lost both her husband and hers cards. When they got second one, they said to call Pfizer to see if Pfizer can provide the lot number for the first dose. On the card for the second dose, they just listed the date and that it was Pfizer, but did not include the lot number for the first dose. She was a nurse practitioner but she is retired now. She did not have an address or email for primary care provider. Headache lasted 48 hours and it improved. Low grade temp improved within 24 hours. Malaise improved within 48 hours. Coughing for 24 hours then improved. Stomach pain resolved 26Feb2021. Everything resolved within 2 days. Arm pain lasted 24 hours. She cannot find it, so when they had second shot, they wrote the date and Pfizer, but no lot number. Second dose was given on 17Mar2021, Lot EN6205, Expiration unknown. Injected in left arm in the muscle. Causality not provided for events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
fatigue, achy joints, couldn't get out of bed;CBC & platelet low;dx lupus;
Right side upper chest hurt, sleepy, fever, body aches, headache, joint pain, lower back pain, nightmares
After receiving the vaccine my hands swelled up about 18 hours later. I was unable to even pick up a cup, I took Ibuprofen and the pain was better and the swelling went down. It is still happening to this day.